“Best Practice in Personalised Medicine” Recognition 2022 – now open for applications

The International Consortium for Personalised Medicine launched its fifth Recognition. The objective of the ICPerMed Recognition 2022 is to honour, encourage, promote and disseminate outstanding examples of Clinical Research in Personalised Medicine using clinical datasets and technology to fruitfully impact the Regional, National, and International data sharing among patients, health professionals, and researchers. The deadline for the submission of the proposals is June 30th, 2022.

The application (from all over the world) should represent a good practice example of at least one of the following aspects of Data Sharing:

  1. Use of innovative technologies/infrastructures for data exchange.
  2. Examples of efficient data sharing, engaging citizens, patients, healthcare professionals, and researchers, economically beneficial, and avoiding redundancies/data loss.
  3. Regional, National, and International Data exchange, with a special focus on data sharing across EU and non-EU countries or countries with different Data Protection Regulations.

The selected authors will be invited to the next ICPerMed Conference – Prelude to the Future of Medicine to be held in Paris on October 5-6, and will be allowed to present their results during a plenary session. In addition, the awarded candidates will receive a €500 non–cash contribution for the dissemination of the Best Practice Example.

Further details on the ICPerMed “Best Practice in Personalised Medicine” Recognition 2022 and on the application process is available here:

Call for Applications

Application Form

For further questions please contact:

Phone: +39 0659946514

For more information about the programme and to register to the conference: ICPerMed Conference – Prelude to the Future of Medicine

ICPerMed was established in November 2016 and comprises over 40 European and international members representing research and health ministries as well as funding agencies, including the European Commission as observer. The aim of ICPerMed is to boost personalised medicine by an enhanced coordination and alignment of research activities.

The French National Research Agency (ANR) is implicated in ICPerMed as well as in the ICPerMed Coordination and Support Action (ICPerMed Secretariat; CSA), ERA PerMed, the ERA Net on Personalised Medicine and EU-Africa PerMed.

More information about the different programmes around Personalised Medicine.

Last updated on 17 May 2022
Sign up for the latest news:
Subscribe to our newsletter